BACKGROUND: Promoter methylation is a common epigenetic mechanism to silence tumor suppressor genes during breast cancer development. We investigated whether BRCA1-associated breast tumors show cancer-predictive methylation patterns similar to those found in sporadic tumors. PATIENTS AND METHODS: Quantitative multiplex methylation-specific PCR of 11 genes involved in breast carcinogenesis (RARB, RASSF1, TWIST1, CCND2, ESR1, SCGB3A1, BRCA1, BRCA2, CDKN2A, APC, CDH1) was carried out on 32 BRCA1-associated and 46 sporadic breast carcinomas and on normal breast tissue from seven BRCA1 mutation carriers and 13 non-carriers. RESULTS: The extent of cumulative methylation increased with age (P < 0.001). The median cumulative methylation index (CMI) of all studied genes was significantly higher in tumors (89) than in normal tissue (13, P < 0.001). The median CMI was significantly lower in BRCA1-associated (59) than in sporadic breast tumors (122, P = 0.001), in estrogen receptor (ER)-negative tumors (73) than in ER-positive tumors (122, P = 0.005) and in lymph node-negative (77) compared with lymph node-positive tumors (137, P = 0.007). In subgroup analysis, the effect of a BRCA1 germline mutation on methylation proved to be independent of ER status, lymph node status and age. CONCLUSIONS: These data indicate that BRCA1-associated breast cancers show less promoter methylation compared with sporadic breast carcinomas indicating a difference in disease etiology.
BACKGROUND: Promoter methylation is a common epigenetic mechanism to silence tumor suppressor genes during breast cancer development. We investigated whether BRCA1-associated breast tumors show cancer-predictive methylation patterns similar to those found in sporadic tumors. PATIENTS AND METHODS: Quantitative multiplex methylation-specific PCR of 11 genes involved in breast carcinogenesis (RARB, RASSF1, TWIST1, CCND2, ESR1, SCGB3A1, BRCA1, BRCA2, CDKN2A, APC, CDH1) was carried out on 32 BRCA1-associated and 46 sporadic breast carcinomas and on normal breast tissue from seven BRCA1 mutation carriers and 13 non-carriers. RESULTS: The extent of cumulative methylation increased with age (P < 0.001). The median cumulative methylation index (CMI) of all studied genes was significantly higher in tumors (89) than in normal tissue (13, P < 0.001). The median CMI was significantly lower in BRCA1-associated (59) than in sporadic breast tumors (122, P = 0.001), in estrogen receptor (ER)-negative tumors (73) than in ER-positive tumors (122, P = 0.005) and in lymph node-negative (77) compared with lymph node-positive tumors (137, P = 0.007). In subgroup analysis, the effect of a BRCA1 germline mutation on methylation proved to be independent of ER status, lymph node status and age. CONCLUSIONS: These data indicate that BRCA1-associated breast cancers show less promoter methylation compared with sporadic breast carcinomas indicating a difference in disease etiology.
Authors: M Esteller; M F Fraga; M Guo; J Garcia-Foncillas; I Hedenfalk; A K Godwin; J Trojan; C Vaurs-Barrière; Y J Bignon; S Ramus; J Benitez; T Caldes; Y Akiyama; Y Yuasa; V Launonen; M J Canal; R Rodriguez; G Capella; M A Peinado; A Borg; L A Aaltonen; B A Ponder; S B Baylin; J G Herman Journal: Hum Mol Genet Date: 2001-12-15 Impact factor: 6.150
Authors: William B Archey; Kristen A McEachern; Mark Robson; Kenneth Offit; Susan A J Vaziri; Graham Casey; Ake Borg; Bradley A Arrick Journal: Oncogene Date: 2002-10-10 Impact factor: 9.867
Authors: C T Brekelmans; C Seynaeve; C C Bartels; M M Tilanus-Linthorst; E J Meijers-Heijboer; C M Crepin; A A van Geel; M Menke; L C Verhoog; A van den Ouweland; I M Obdeijn; J G Klijn Journal: J Clin Oncol Date: 2001-02-15 Impact factor: 44.544
Authors: Ji Shin Lee; Mary Jo Fackler; Jae Hyuk Lee; Chan Choi; Min Ho Park; Jung Han Yoon; Zhe Zhang; Saraswati Sukumar Journal: Cancer Biol Ther Date: 2010-06-18 Impact factor: 4.742
Authors: Jolien S de Groot; Xiaojuan Pan; Jan Meeldijk; Elsken van der Wall; Paul J van Diest; Cathy B Moelans Journal: Cell Oncol (Dordr) Date: 2014-08-16 Impact factor: 6.730
Authors: James M Flanagan; Sibylle Cocciardi; Nic Waddell; Cameron N Johnstone; Anna Marsh; Stephen Henderson; Peter Simpson; Leonard da Silva; Kumkum Khanna; Sunil Lakhani; Chris Boshoff; Georgia Chenevix-Trench Journal: Am J Hum Genet Date: 2010-03-04 Impact factor: 11.025
Authors: Karolina Holm; Cecilia Hegardt; Johan Staaf; Johan Vallon-Christersson; Göran Jönsson; Håkan Olsson; Ake Borg; Markus Ringnér Journal: Breast Cancer Res Date: 2010-06-18 Impact factor: 6.466